NORWALK, Conn., MILWAUKEE, and ISFIYA, Israel―GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company, announced today an investment in Check-Cap, Ltd., a developer of an ingestible imaging capsule that may help detect colorectal cancer. The investment is being made through the GE healthymagination Fund, an equity fund that makes investments in healthcare technology companies.
Check-Cap's ingestible and disposable imaging capsule is planned to have the capability to image the colon in 3D. The capsule will require no bowel cleansing before ingestion and no hospital visit, allowing patients to go about their daily routines without having to alter their activities.
"Check-Cap's technology is not only innovative but it presents great promise to change the standard of patient care and to help them avoid the discomfort of traditional colonoscopies," said GE vice president and GE healthcare chief technology officer Mike Harsh.
The investment is aligned with GE Healthcare's expanding focus on colon-cancer management solutions that can improve healthcare globally, as well as GE's broader healthymagination initiative, which focuses on reducing cost, increasing patient access and improving quality in healthcare. Financial terms of the transaction were not disclosed.